The<unk>  Carnot Institute (Consortium for the Acceleration of Innovation and its Transfer in the Lymphoma Field) is an academic research consortium focusing in lymphoma treatments and diagnosis spanning from new target identification to large international Phase III clinical trials and beyond.<unk>  brings together 20 entities with complementary expertise in preclinical, translational and clinical lymphoma research: the Lymphoma Study Association (LYSA), the Lymphoma Academic Research Organisation (LYSARC), and 18 public preclinical research teams in lymphoma based at universities and hospitals across France. The consortium aims at accelerating innovation and its transfer in the lymphoma field, particularly in the translational phase and in the areas of therapeutic, diagnosis and imaging. The<unk>  Carnot institute is managed by Bertrand Nadel. The steering committee of<unk>  consortium is led by Guillaume Cartron. Carnot Institute is a label of excellence awarded by the French Ministry of Research to public-parapublic research institutes with a strong track record of partnering research.
CALYM
SCALPEL
COCIR
MCN
GL-ONC1
BIM-1
CoWIN
FOSB